Branded Rx · FDA-approved for chronic weight management

Wegovy®

FDA-approved semaglutide, indicated for chronic weight management.

Wegovy is the FDA-approved branded semaglutide indicated specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. Manufactured by Novo Nordisk. At Cypress, you pay up front and submit to your insurance for reimbursement.

  • FDA-approved for chronic weight management
  • Once-weekly subcutaneous injection
  • Manufactured by Novo Nordisk
  • Pay up front, submit to your insurance for reimbursement
  • Clinician oversight and pharmacy coordination included
Start your assessment

Why Wegovy specifically

The semaglutide indicated for weight, not diabetes.

Woman in midlife considering her care options

Wegovy and Ozempic share an active ingredient (semaglutide) but have different FDA-approved indications. Wegovy is approved for chronic weight management. For some insurance plans, the indication on the prescription matters — coverage rules differ between Wegovy and Ozempic.

If your insurance plan has clear coverage criteria for chronic weight management, Wegovy can be the more reimbursable choice. Your clinician will help you decide.

Cypress is not affiliated with Novo Nordisk. Wegovy is a registered trademark of its respective owner.

How Cypress branded works

What we do, and what we don't.

1
We prescribe and coordinate
Your clinician evaluates whether branded GLP-1 is appropriate, prescribes it, and coordinates with a pharmacy.
2
You pay up front
You pay the full cost at fulfillment. We confirm the price with you first.
3
You file the claim
We provide all documentation needed. You submit to your plan; they reimburse you directly. We do not bill insurance.

Side effects & safety

What to know before you start.

Woman reviewing health information at home

Most common: nausea, decreased appetite, mild diarrhea, constipation, fatigue.

Less common but important: pancreatitis, gallbladder issues, low blood sugar.

Not appropriate if: personal/family history of medullary thyroid carcinoma or MEN2; pregnant, planning pregnancy, or breastfeeding; severe GI or end-stage organ disease.

The branded path. Start today.

The 3-minute medical screener is free. We'll ask about your insurance early.

Start your assessment